We take a look back at our 2023 coverage of blunders that prompted retractions in the neuroscience literature in this archival special report.
SourceSource: Spectrum News
This month’s Going on Trial newsletter dives into an electroencephalography biomarker that could track the efficacy of treatments for dup15q and Angelman syndromes, among other drug development news.
SourceSource: Spectrum News
Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.
SourceSource: Spectrum News
A protective pathway that pauses protein synthesis is muted in a mouse model of fragile X syndrome, according to a new study.
SourceSource: Spectrum News
This week on social media, researchers discussed a genome-wide association study of the human cerebral cortex, how astrocytes integrate calcium signals, and more.
SourceSource: Spectrum News
But the field needs to move on from cross-sectional studies to gain insights into the causes and consequences of the association, experts say.
SourceSource: Spectrum News
Researchers reacted to a study of brain mitochondria and behavior in mice and a study of brain structure differences in autism and other conditions. That and more in this week’s Community Newsletter.
SourceSource: Spectrum News